ArticleFrontiers in oncology2026
Intracranial angiomatoid fibrous histiocytoma in a 2-month-old infant: a rare case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Angiomatoid fibrous histiocytoma (AFH) is a rare tumor typically arising in the extremities or trunk. Its intracranial occurrence in young infants constitutes a distinct rarity that poses significant clinical challenges. This report details the diagnosis and management of AFH in a 2-month-old infant with an intracranial lesion. Case description: A 2-month-old female infant presented with a postauricular mass. Magnetic resonance imaging (MRI) and computed tomography (CT) confirmed an intracranial tumor. Subsequent craniotomy revealed a 4 × 3 × 4 cm epidural mass between the dura mater and galea aponeurotica. Histopathology confirmed a rare intracranial AFH. Conclusion: Intracranial AFH in infants is exceedingly rare, requiring definitive diagnosis through immunohistochemistry and molecular genetic testing. Complete surgical resection represents the gold-standard management; however, limited experience in treating very young infants necessitates meticulous intraoperative hemostasis and robust collaboration with pathologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.